Healthcare provider profile · identity verified

Hugo G Jauregui, MD

Internal Medicine · DARTMOUTH, MA · NPI 1124084611

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1094	291
Omeprazole	Omeprazole	626	184
Metoprolol Succinate	Metoprolol Succinate	592	155
Lisinopril	Lisinopril	584	155
Amlodipine Besylate	Amlodipine Besylate	544	147
Furosemide	Furosemide	344	108
Metformin Hcl	Metformin Hcl	336	103
Levothyroxine Sodium	Levothyroxine Sodium	328	87
Losartan Potassium	Losartan Potassium	306	87
Pravastatin Sodium	Pravastatin Sodium	292	73
Simvastatin	Simvastatin	270	78
Eliquis	Apixaban	267	73
Pantoprazole Sodium	Pantoprazole Sodium	257	70
Rosuvastatin Calcium	Rosuvastatin Calcium	252	73
Gabapentin	Gabapentin	225	59
Tamsulosin Hcl	Tamsulosin Hcl	223	59
Hydrochlorothiazide	Hydrochlorothiazide	205	57
Trazodone Hcl	Trazodone Hcl	203	60
Metoprolol Tartrate	Metoprolol Tartrate	198	56
Sertraline Hcl	Sertraline Hcl	188	55
Fluticasone Propionate	Fluticasone Propionate	176	69
Clopidogrel	Clopidogrel Bisulfate	170	45
Allopurinol	Allopurinol	166	38
Carvedilol	Carvedilol	140	40
Famotidine	Famotidine	131	35
Albuterol Sulfate Hfa	Albuterol Sulfate	127	52
Potassium Chloride	Potassium Chloride	125	37
Lorazepam	Lorazepam	111	45
Citalopram Hbr	Citalopram Hydrobromide	103	29
Meloxicam	Meloxicam	102	35
Ozempic	Semaglutide	101	17
Prednisone	Prednisone	101	67
Warfarin Sodium	Warfarin Sodium	96	16
Alprazolam	Alprazolam	95	30
Fluoxetine Hcl	Fluoxetine Hcl	95	29
Atenolol	Atenolol	92	27
Finasteride	Finasteride	90	30
Glipizide	Glipizide	89	22
Montelukast Sodium	Montelukast Sodium	88	27
Lovastatin	Lovastatin	79	23
Ibuprofen	Ibuprofen	72	28
Celecoxib	Celecoxib	71	23
Metformin Hcl Er	Metformin Hcl	70	25
Tramadol Hcl	Tramadol Hcl	63	27
Meclizine Hcl	Meclizine Hcl	62	28
Triamcinolone Acetonide	Triamcinolone Acetonide	62	29
Donepezil Hcl	Donepezil Hcl	60	16
Labetalol Hcl	Labetalol Hcl	60	14
Breo Ellipta	Fluticasone/Vilanterol	59	11
Mirtazapine	Mirtazapine	59	15
Amitriptyline Hcl	Amitriptyline Hcl	58	13
Ezetimibe	Ezetimibe	56	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	18
Jardiance	Empagliflozin	55	16
Escitalopram Oxalate	Escitalopram Oxalate	54	16
Quetiapine Fumarate	Quetiapine Fumarate	54	12
Tizanidine Hcl	Tizanidine Hcl	54	11
Alendronate Sodium	Alendronate Sodium	53	16
Doxycycline Hyclate	Doxycycline Hyclate	51	48
Glipizide Er	Glipizide	51	17
Doxazosin Mesylate	Doxazosin Mesylate	50	12
Azithromycin	Azithromycin	48	45
Spironolactone	Spironolactone	45	16
Duloxetine Hcl	Duloxetine Hcl	44	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	13
Ventolin Hfa	Albuterol Sulfate	44	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	42	25
Diclofenac Sodium	Diclofenac Sodium	41	14
Glimepiride	Glimepiride	41	14
Chlorthalidone	Chlorthalidone	40	12
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Clonazepam	Clonazepam	36	suppressed
Enalapril Maleate	Enalapril Maleate	36	11
Imipramine Hcl	Imipramine Hcl	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	13
Levetiracetam	Levetiracetam	35	suppressed
Xarelto	Rivaroxaban	33	13
Methylprednisolone	Methylprednisolone	32	30
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	11
Betamethasone Dipropionate	Betamethasone Dipropionate	30	12
Myrbetriq	Mirabegron	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	11
Gemfibrozil	Gemfibrozil	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	16
Glycopyrrolate	Glycopyrrolate	25	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Naproxen	Naproxen	24	suppressed
Nystatin	Nystatin	24	11
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Valsartan	Valsartan	23	suppressed
Ciclopirox	Ciclopirox Olamine	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Diazepam	Diazepam	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Folic Acid	Folic Acid	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Memantine Hcl	Memantine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Pentoxifylline	Pentoxifylline	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Digoxin	Digoxin	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nystop	Nystatin	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error